We are a global, science-led, patient-focused pharmaceutical company. We are dedicated to transforming the future of healthcare by unlocking the power of what science can do for people, society and the planet. We are focused on creating genuinely innovative medicines and improving access to them. In this way, we deliver the greatest benefit to patients, healthcare systems and societies globally.
Visit the AstraZeneca website
AstraZeneca has five (5) global Research and Development (R&D) centers. These include:
- Cambridge, UK
- Gaithersburg, MD (USA)
- Gotenburg, Sweden
- Boston, MA (USA)
- Shanghai, China
AstraZeneca has five (5) therapy areas of focus. These include:
- Oncology
- Cardiovascular-Renal-
Metabolism - Respiratory/Immunology
- Vaccines/Immune Therapies
- Rare Diseases
The Biologics License Application (BLA) is used to request permission to introduce, or deliver a biologic product into interstate commerce. It is a necessary process for AstraZeneca in biopharmaceutical drug development.
Slide deck Shown at Sponsor Table during the PM Symposium
